Effects of inhaled JAK inhibitor GDC-4379 on exhaled nitric oxide and peripheral biomarkers of inflammation
Authors:
- Hubert ChenHCHubert Chen
- Rebecca KunderRKRebecca Kunder
- Yixuan ZouYZYixuan Zou
- Tracy StatonTSTracy Staton
- Rui ZhuRZRui Zhu
- Joshua GalanterJGJoshua Galanter
- Hallam GugelmannHGHallam Gugelmann
- Ryan OwenRORyan Owen
- Michele A. GrimbaldestonMGMichele A. Grimbaldeston
- Joanna K. ChangJCJoanna K. Chang
- Matthew R. DurkMDMatthew R. Durk
- Avi EliahuAEAvi Eliahu
- 26 May 2022
- journal article
- research article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 75, 102133
Abstract
No abstract availableKeywords
Funding Information
- Genentech
- AstraZeneca
This publication has 22 references indexed in Scilit:
- Mepolizumab Treatment in Patients with Severe Eosinophilic AsthmaNew England Journal of Medicine, 2014
- Dupilumab in Persistent Asthma with Elevated Eosinophil LevelsNew England Journal of Medicine, 2013
- Asthma phenotypes: the evolution from clinical to molecular approachesNature Medicine, 2012
- Optimisation of DMPK by the Inhaled Route: Challenges and ApproachesCurrent Drug Metabolism, 2012
- Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trialBMC Pulmonary Medicine, 2011
- Lebrikizumab Treatment in Adults with AsthmaNew England Journal of Medicine, 2011
- An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (F e NO) for Clinical ApplicationsAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Rapid Effect of Inhaled Ciclesonide in AsthmaChest, 2008
- Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthmaThorax, 2002
- JAK-STAT signaling in asthmaJournal of Clinical Investigation, 2002